Evidence map›Paper›PMID 34290883›Full record

ReviewFuture science OA2021

The COVID-19 pandemic: a threat to antimicrobial resistance containment.

Raspail C Founou, Ariel J Blocker, Michel Noubom, Cedrice Tsayem, Siméon P Choukem, Maarten Van Dongen, Luria L Founou

Abstract readReview
In one paragraph

Review in Future science OA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. New microbes and new infections · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Genomic insights and evaluation ofFrontiers in cellular and infection microbiology · 2026
    Article
  11. Epidemiological profile of urinary tract infections in children before and during the COVID-19 pandemic: an observational study.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2026
    Observational
  12. Article
  13. Review
  14. In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-β-lactamase producers.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Quorum Sensing and its Inhibition inCurrent drug targets · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raspail C FounouDepartment of Microbiology, Hematology & Immunology, Faculty of Medicine & Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.ORCID https://orcid.org/0000-0002-9866-2103
Ariel J BlockerAMR Insights Ambassador Network, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-8705-2641
Michel NoubomDepartment of Microbiology, Hematology & Immunology, Faculty of Medicine & Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
Cedrice TsayemDepartment of Clinical Biochemistry, Centre of Expertise & Biological Diagnostic of Cameroon, Yaoundé, Cameroon.
Siméon P ChoukemUnited COVID-19 TaskForce, University of Dschang, Dschang, Cameroon.ORCID https://orcid.org/0000-0003-1399-5513
Maarten Van DongenAMR Insights Ambassador Network, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-3212-3924
Luria L FounouAMR Insights Ambassador Network, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-3874-8175

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As of 23 April 2021, the outbreak of COVID-19 claimed around 150 million confirmed cases with over 3 million deaths worldwide. Yet, an even more serious but silent pandemic, that of antimicrobial resistance (AMR), is likely complicating the outcome of COVID-19 patients. This study discusses the current knowledge on the emergence of the SARS-CoV-2 and highlights the likely contribution of the COVID-19 pandemic on the escalation of AMR. COVID-19 engenders extensive antibiotic overuse and misuse, and will undoubtedly and substantially increase AMR rates worldwide. Amid the expanding COVID-19 pandemic, policymakers should consider the hidden threat of AMR much more, which may well be enhanced through improper use of antibiotics to treat patients with severe COVID-19 infection.

Indexed as

antimicrobial resistanceantimicrobial stewardshipCOVID-19 pandemicCOVID-19 vaccinesSARS-CoV-2

Identifiers

PMID34290883
PMCPMC8204817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.